Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 04/08/20 | 8-K | Current report filing |
|
3 | |
| 04/08/20 | S-3 | Registration statement for specified transactions by certain issuers |
|
85 | |
| 03/30/20 | DEF 14A | Definitive proxy statements |
|
75 | |
| 03/24/20 | 8-K | Current report filing |
|
51 | |
| 03/24/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
173 |
| 03/20/20 | 8-K | Current report filing |
|
11 | |
| 03/18/20 | 4 | Treco James |
|
2 | |
| 03/03/20 | 8-K | Current report filing |
|
45 | |
| 02/28/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
58 | |
| 02/28/20 | 8-K | Current report filing |
|
55 |
